A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : DS / diameter stenosis

[Related PubMed/MEDLINE]
Total Number of Papers: 107
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   DS  (>> Co-occurring Abbreviation)
Long Form:   diameter stenosis
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Computationally simulated fractional flow reserve from coronary computed tomography angiography based on fractional myocardial mass. FFR, S-FFR
2019 Polymer-free drug-eluting stents versus permanent polymer drug-eluting stents: An updated meta-analysis. CI, LLL, PF-DES, PP-DES, RRs, SMDs, TLR
2018 Advanced analyses of computed tomography coronary angiography can help discriminate ischemic lesions. CTCA, DCV, FFR, LAP, LL, MLA, NP Vol, NR, SFR
2018 Angiography Versus Hemodynamics to Predict the Natural History of Coronary Stenoses: Fractional Flow Reserve Versus Angiography in Multivessel Evaluation 2 Substudy. FFR, VOCE
2018 Computation of hemodynamics in eccentric coronary stenosis: A morphological parametric study. EI, SL
2018 Diagnostic performance of machine-learning-based computed fractional flow reserve (FFR) derived from coronary computed tomography angiography for the assessment of myocardial ischemia verified by invasive FFR. CCTA, cFFR, FFR, MJI, ML-based
2018 Fractional Flow Reserve Estimated at Coronary CT Angiography in Intermediate Lesions: Comparison of Diagnostic Accuracy of Different Methods to Determine Coronary Flow Distribution. AUC, CT, FFR
2018 Machine learning assessment of myocardial ischemia using angiography: Development and retrospective validation. ABLE, AUC, CAMS, CCTA, FFR, GBM, LAD, LCX, MAEs, ML, RCA
2018 Myocardial Mass Contributes to the Discrepancy Between Anatomic Stenosis Severity Assessed by Intravascular Ultrasound and Fractional Flow Reserve in Intermediate Lesions of the Coronary Artery. BCV, FFR, LAD, MLA
10  2018 Percutaneous transcatheter aortic valve replacement induces femoral artery shrinkage: angiographic evidence and predictors for a new side effect. CFA, MLD, TAVR
11  2018 Simplified Bernoulli formula to predict flow limiting stenosis at coronary computed tomography angiography. CI, EEL, FFR
12  2018 The natural course of nonculprit coronary artery lesions; analysis by serial quantitative coronary angiography. CI, HR, IDR
13  2018 The transluminal attenuation gradient in coronary CT angiography for the detection of hemodynamically significant disease: can all arteries be treated equally? AUC, CCTA, FFR, ROC, TAG
14  2017 A head to head comparison of XINSORB bioresorbable sirolimus-eluting scaffold versus metallic sirolimus-eluting stent: 180 days follow-up in a porcine model. LLL, OCT
15  2017 Abdominal pain in patient with antiphospholipid syndrome-the role of MDCT angiography on visceral blood vessels. aPL, APS, MDCT, PAPS, SAPS
16  2017 Correlation between Angiographic and Physiologic Evaluation of Coronary Artery Narrowings in Patients With Aortic Valve Stenosis. AS, CAD, FFR, LAD
17  2017 Efficacy and safety of polymer-free stent versus polymer-permanent drug-eluting stent in patients with acute coronary syndrome: a meta-analysis of randomized control trials. CD, LLL, MACE, MI, PCI, PFS, PPDES, RCTs, ST, TLR
18  2017 Stenotic flow reserve derived from quantitative coronary angiography has modest but incremental value in predicting functionally significant coronary stenosis as evaluated by fractional flow reserve. FFR, MLD, PR, QCA, ROC, SFR, TR
19  2017 The role of MSCT angiography in early detection of lower limb arterial lesions in patients with antiphospholipid syndrome. 64-MSCT, APS, PAPS, SAPS
20  2016 Can "true bifurcation lesion" actually be regarded as an independent risk factor of acute side branch occlusion after main vessel stenting?: A retrospective analysis of 1,200 consecutive bifurcation lesions in a single center. MV, SB, TBL
21  2016 Multimodality imaging of attenuated plaque using grayscale and virtual histology intravascular ultrasound and optical coherent tomography. IVUS, OCT, OCT, TCFA, VH-IVUS
22  2016 Physiological Severity of Coronary ArteryStenosis Depends on the AmountofMyocardial Mass Subtended bythe Coronary Artery. CCTA, FFR, FMM, FMM/MLD, IDI, MLD, NRI
23  2016 Simplified Models of Non-Invasive Fractional Flow Reserve Based on CT Images. AUC, CFD, CTA, FFR
24  2016 Statin therapy and inflammation in patients with diabetes treated with high dose aspirin. CAD
25  2016 The Incremental Prognostic Value of Cardiac Computed Tomography in Comparison with Single-Photon Emission Computed Tomography in Patients with Suspected Coronary Artery Disease. CACS, CAD, CCTA, CP, MP, NCP, PD, SPECT
26  2016 When should fractional flow reserve be performed to assess the significance of borderline coronary artery lesions: Derivation of a simplified scoring system. FFR, SSS
27  2015 Association of morphologic characteristics on optical coherence tomography and angiographic progression patterns of late restenosis after drug-eluting stent implantation. CAG, DES, OCT
28  2015 Comparison between two- and three-dimensional quantitative coronary angiography bifurcation analyses for the assessment of bifurcation lesions: A subanalysis of the TRYTON pivotal IDE coronary bifurcation trial. MLD, QCA
29  2015 Morphological analysis of the left ventricular endocardial surface using a bag-of-features descriptor. CAD, LV, MDCT
30  2015 Quantification of coronary artery Stenosis by Area Stenosis from cardiac CT angiography. AS, CTA
31  2015 Vitamin D status was not associated with 'one-year' progression of coronary artery disease, assessed by coronary angiography in statin-treated patients. CA, CAD, CI, MLD
32  2014 Diagnostic uncertainties during assessment of serial coronary stenoses: an in vitro study. AS, CDP, FFR
33  2014 Evolving concepts of angiogram: fractional flow reserve discordances in 4000 coronary stenoses. FFR
34  2014 Functional and morphological assessment of side branch after left main coronary artery bifurcation stenting with cross-over technique. FFR, IVUS, LCX, LMCA, MB, MLA, NPV, PPV
35  2014 Numerical simulation and clinical implications of stenosis in coronary blood flow. CFD, CTA, FFR, LAD
36  2013 Advanced three-dimensional quantitative coronary angiographic assessment of bifurcation lesions: methodology and phantom validation. BA, MLD, QCA, RVD
37  2013 Prognostic value of renal fractional flow reserve in blood pressure response after renal artery stenting (PREFER study). ABPM, MLD, rFFR, TSPG
38  2013 The association between progression of atherosclerosis and the methylated amino acids asymmetric dimethylarginine and trimethyllysine. ADMA, CAD, FA, PCI, QCA, SAM, TML, WENBIT
39  2012 Advances in two-dimensional quantitative coronary angiographic assessment of bifurcation lesions: improved small lumen diameter detection and automatic reference vessel diameter derivation. BA, MLD, QCA, RVD
40  2012 Comparison of the efficacy and safety of statin and statin/ezetimibe therapy after coronary stent implantation in patients with stable angina. LDL-C
41  2012 Functional assessment of jailed side branches in coronary bifurcation lesions using fractional flow reserve. CI, FFR, OR, QCA
42  2012 Impact of the presence and extent of incomplete angiographic revascularization after percutaneous coronary intervention in acute coronary syndromes: the Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trial. ACUITY, ICR
43  2012 Plaque volume derived from three-dimensional reconstruction of coronary angiography predicts the fractional flow reserve. AS, AUC, FFR, MLD, PV, ROC
44  2012 Prediction of acute cardiac events in patients with noncalcified plaques using dual-source CT angiography. ACE, CCTA
45  2012 Validity and variability in visual assessment of stenosis severity in phantom bifurcation lesions: a survey in experts during the fifth meeting of the European Bifurcation Club. DMV, PMV, QCA, SB
46  2012 Visual-functional mismatch between coronary angiography and fractional flow reserve. FFR, IVUS
47  2012 [Effects of domestic rosuvastatin on coronary plaque in patients with mild-to-moderate coronary artery stenosis as evaluated by virtual histology-intravascular ultrasound]. ACS, HDL-C, LDL-C, MLA, QCA, TC, TG, VH-IVUS
48  2011 Analysis of pulsatile and nonpulsatile blood flow effects in different degrees of stenotic vasculature. EEP, KH-VAD, SHE
49  2011 Angiographic disease progression and residual risk of cardiovascular events while on optimal medical therapy: observations from the COURAGE Trial. OMT, PCI
50  2011 Assessment of renal artery stenosis using both resting pressures ratio and fractional flow reserve: relationship to angiography and ultrasonography. MLD, RAR, RAS, rFFR, RI, TSPG
51  2011 Novel bifurcation phantoms for validation of quantitative coronary angiography algorithms. BA, MLD, QCA
52  2011 Percutaneous transluminal angioplasty versus turbostatic carbon-coated stents in infrapopliteal arteries: InPeria II trial. CLI, MLD, PTA
53  2011 Two-dimensional quantitative coronary angiographic models for bifurcation segmental analysis: in vitro validation of CAAS against precision manufactured plexiglas phantoms. AP, BA, MLD, QCA, RVD
54  2010 A pooled gender based analysis comparing the XIENCE V(R) everolimus-eluting stent and the TAXUS paclitaxel-eluting stent in male and female patients with coronary artery disease, results of the SPIRIT II and SPIRIT III studies: two-year analysis. EES, LL, MACE, PES, TVF
55  2010 Clinical and angiographic outcomes after bare metal stents implantation for the patients with acute ST-elevation myocardial infarction: insights from multicenter trials. BMS, MLD, QCA, RD, STEMI, TLR
56  2010 Correlations between progression of coronary artery disease and circulating endothelial progenitor cells. CAD, EPCs
57  2009 Determination of haemodynamic significance of intermediate coronary lesions using three-dimensional coronary reconstruction. CSS, FFR, IL, PV, QCA
58  2009 Human coronary atherosclerosis modulates cardiac natriuretic peptide release. CPT, FFR, NPs
59  2009 Novel fully bioabsorbable salicylate-based sirolimus-eluting stent. AS, IVUS, OCT, QCA, SES
60  2008 Comparison of quantitative coronary angiography and first-pass perfusion magnetic resonance imaging for the detection of an impaired coronary perfusion in nonsevere coronary stenosis. AUC, CFVR, FPP-MRI, MPRI, QCA, ROC
61  2008 Diagnostic accuracy of quantitative cardiac MRI evaluation compared to stress single-photon-emission computed tomography. CAD, CMRI, MPR, QCA, SPECT
62  2008 Hemodynamic evaluation of coronary artery bypass graft lesions using fractional flow reserve. FFR, MPI, SVG
63  2008 The porcine restenosis model using thermal balloon injury: comparison with the model by coronary stenting. PCI
64  2008 Why can pulmonary vein stenoses created by radiofrequency catheter ablation worsen during and after follow-up? A potential explanation. PV
65  2007 Diagnostic accuracy of 16-slice multidetector-row CT for detection of in-stent restenosis vs detection of stenosis in nonstented coronary arteries. MDCT, QCA
66  2007 Evaluation of cardiac magnetic resonance imaging parameters to detect anatomically and hemodynamically significant coronary artery disease. CAD, CMR, FFR, MPR
67  2007 Predictors of aorto-saphenous vein bypass narrowing late after coronary artery bypass grafting. ABS, CABG, CI, HDL, OR, SVG
68  2007 Quantitative magnetic resonance perfusion imaging detects anatomic and physiologic coronary artery disease as measured by coronary angiography and fractional flow reserve. CAD, CMR, FFR, MPR
69  2006 Lower level of low-density lipoprotein cholesterol by statin prevents progression of coronary restenosis after successful stenting in acute myocardial infarction. AMI, CRP, LDL, QCA
70  2006 Rapid decline of collateral circulation increases susceptibility to myocardial ischemia: the trade-off of successful percutaneous recanalization of chronic total occlusions. DES, FFRcoll, MLD, PCI, SigmaST
71  2006 Usefulness of translesional pressure gradient and pharmacological provocation for the assessment of intermediate renal artery disease. ACh, RAS, TSPG
72  2005 Head-to-head comparison of three-dimensional navigator-gated magnetic resonance imaging and 16-slice computed tomography to detect coronary artery stenosis in patients. AUC, MDCT, MR, QCA
73  2005 Novel index of coronary collateral development as a useful predictor of clinical outcome in type 2 diabetic patients with coronary artery disease. CAD, CD, cTFC, PTCA
74  2004 Effect of acute myocardial infarction on the utility of fractional flow reserve for the physiologic assessment of the severity of coronary artery narrowing. AMI, FFR, MLD
75  2004 Oral rapamycin to prevent human coronary stent restenosis: a pilot study. ---
76  2004 Serial six year quantitative angiographic follow up in asymptomatic patients following successful coronary angioplasty. MLD
77  2003 Clinical and angiographic outcome of patients with mild coronary lesions treated with balloon angioplasty or coronary stenting. Implications for mechanical plaque sealing. BA, HR, MI, PCI, QCA
78  2003 Early and late outcome of stenting in a consecutive series of patients with coronary lesions in vessels less than 2.8 mm in diameter. RVD
79  2003 Thrombin-activatable fibrinolysis inhibitor (TAFI): a novel predictor of angiographic coronary restenosis. TAFI
80  2003 Variability of quantitative coronary angiography: an evaluation of on-site versus core laboratory analysis. MLD, QCA, RD, SISCA
81  2002 A randomized comparison of the value of additional stenting after optimal balloon angioplasty for long coronary lesions: final results of the additional value of NIR stents for treatment of long coronary lesions (ADVANCE) study. BA, MACE, QCA
82  2002 Area ablation: a new lasing concept provides significantly enhanced acute and long-term results for treatment of in-stent restenosis. ISR, MACE, MLD, TLR
83  2002 Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials. MI, MLD, TLR, TVF, TVR
84  2002 Coronary hemodynamics of stent implantation after suboptimal and optimal balloon angioplasty. BA, CFR, MACE
85  2002 Intravascular ultrasound and quantitative coronary angiography assessment of late in-stent restenosis: in vivo human correlation and methodological implications. CSA, IH, IVUS, QCA
86  2002 Quantitative angiographic methods for appropriate end-point analysis, edge-effect evaluation, and prediction of recurrent restenosis after coronary brachytherapy with gamma irradiation. ROC, TVR, WRIST
87  2002 Visual assessment of procedural results following treatment with Sr-90 beta-radiation for instent restenosis. IRT, ISR, MACEs, QCA, TVR, VA
88  2001 Extensive development of vulnerable plaques as a pan-coronary process in patients with myocardial infarction: an angioscopic study. maxDS, MI
89  2001 Restenosis after coronary stenting--incidence and predictors. LAD, LCX, MLD, RCA
90  2001 Thrombectomy with the X-SIZER catheter system in the coronary circulation: initial results from a multi-center study. MI, TIMI
91  2000 High-energy eccentric excimer laser angioplasty for debulking diffuse iIn-stent restenosis leads to better acute- and 6-month follow-up results. eccELCA, MACE, MLD, PTCA, TLR
92  2000 Immediate and long-term results comparing coronary versus biliary tubular-slotted stents to treat old obstructed saphenous vein grafts. MLD
93  2000 Six-month outcome after excimer laser coronary angioplasty for diffuse in-stent restenosis in native coronary arteries. ELCA, MLD, PTCA
94  1999 Impact of cilostazol on restenosis after percutaneous coronary balloon angioplasty. ---
95  1999 One-year follow-up after intravascular ultrasound assessment of moderate left main coronary artery disease in patients with ambiguous angiograms. IVUS, LMCA, MLD, QCA
96  1999 Usefulness of fractional flow reserve to predict clinical outcome after balloon angioplasty. FFR, QCA
97  1998 Intravascular ultrasound predictors of angiographic restenosis in lesions treated with Palmaz-Schatz stents. IVUS, MLD, QCA
98  1998 Remodeling after directional coronary atherectomy (with and without adjunct percutaneous transluminal coronary angioplasty): a serial angiographic and intravascular ultrasound analysis from the Optimal Atherectomy Restenosis Study. CSA, DCA, EEM, IVUS, MLD, OARS, QCA
99  1997 Adenosine technetium-99m sestamibi single-photon emission tomography for the assessment of jeopardized myocardium early after acute myocardial infarction. Paradoxical scintigraphic underestimation of jeopardized myocardium in patients with a severe infarct-related stenosis. DSE, SPET
100  1997 Treatment of in-stent restenosis with excimer laser coronary angioplasty: mechanisms and results compared with PTCA alone. CSA, ELCA, IVUS, MLD